All Articles

A new startup from Boston Dynamics veterans is creating interactive character robots for hospitality, moving beyond static animatronics to offer personalized experiences.

Dubai's new Future Finance Week isn't just another conference. It's a calculated move to rewire global capital flows and cement its role as a top financial power.

Crypto exchange WEEX is blurring the lines between digital and traditional assets, betting on AI and a unified platform to redefine the future of trading.

A simple registration error in a high-stakes tournament led to a $250,000 bounty. We deconstruct how one player's mistake became a life-changing win.

A new Navis Pack & Ship isn't just a shipping store; it's a vital link for the region's growing art, tech, and collector economies. Here's why.

A new service, Enginerds Compass, moves beyond counting media mentions to measure genuine narrative shifts in tech, offering verifiable, source-cited insights.

As Steve Markel retires after 50 years, CEO Tom Gayner becomes Chairman, ushering in a new governance model with Co-Presidents and a Leadership Council.

As Neurogene prepares for a key investor conference, all eyes are on its lead candidate for Rett syndrome. The company bets its proprietary EXACT™ technology can solve a critical gene therapy challenge, holding immense promise for patients and investors alike.

As BioVie seeks FDA approval for a pivotal Phase 3 trial, its novel anti-inflammatory drug could usher in a new era for Parkinson's patients.

National Vision is betting that a style-centric, digitally-native makeover for Eyeglass World can capture the modern consumer in a crowded optical market.

Spirit Blockchain Capital rebrands as Impauer Technologies, shedding its crypto-specific identity. Is this a visionary pivot or a desperate escape from a volatile market?

With its operations crippled by sanctions, Sherritt International faces a creditor revolt led by Kyma Capital, which now controls a majority of its key debt.

A $39.2M federal grant isn't just funding a project; it's signaling a revolution to move genetic medicine manufacturing from massive plants to bedside boxes.

Keke Palmer partners with Sanofi to promote an RSV antibody for babies. We explore the breakthrough science and the ethical tightrope of celebrity health advocacy.

With a key permit secured, Phoenix Metals is launching an accelerated 51,500-metre drill program to unlock copper and gold in a storied BC mining district.

Alterome Therapeutics brings on a heavy-hitting CFO in Johanna Mylet, who guided Poseida to an IPO and Roche acquisition. What does this signal for its future?

A century-old Hawaiian institution is going public. We look beyond the financials to see what ASB's Wall Street debut means for its community-first mission.

Solaris Energy Infrastructure massively boosts its financial outlook, fueled by strategic acquisitions and the insatiable power needs of the AI-driven data center boom.

Over a single weekend, Fifth Third integrated Comerica's systems. A look at the massive technical feat and the strategic ambition to build a new banking giant.

IG Wealth Management's deal with Goldman Sachs brings elite strategies to the masses. But what does this mean for your portfolio and Canadian wealth management?